📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition. (2023)

First Author: Fox T

Attributed to: G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/14651858.cd015775

PubMed Identifier: 37491597

Publication URI: http://europepmc.org/abstract/MED/37491597

Type: Journal Article/Review

Volume: 7

Parent Publication: The Cochrane database of systematic reviews

Issue: 7

ISSN: 1361-6137